Canada markets open in 7 hours 29 minutes

Ress Life Investments A/S (RLAINV.CO)

Copenhagen - Copenhagen Real Time Price. Currency in EUR
Add to watchlist
2,112.000.00 (0.00%)
At close: 09:49AM CEST
Full screen
Loading interactive chart...
  • GlobeNewswire

    Ress Life Investments A/S: Ress Life Investments A/S publishes Net Asset Value (NAV)

    Ress Life Investments Nybrogade 12 DK-1203 Copenhagen K Denmark CVR nr. 33593163 www.resslifeinvestments.com To: Nasdaq Copenhagen Date: 15 May 2024 Corporate Announcement 17/2024 Ress Life Investments A/S publishes Net Asset Value (NAV). Ress Life Investments A/S publishes the Net Asset Value (NAV) per share as of 30 April 2024. NAV per share in USD: 2487.09 NAV per share in EUR: 2320.48 The performance during April is 0.53% in USD. The year-to-date net performance is 2.05% in USD. The performa

  • GlobeNewswire

    Ress Life Investments A/S: Ress Life Investments A/S publishes portfolio composition for Q1 2024

    Ress Life Investments A/SNybrogade 12DK-1203 CopenhagenDenmarkCVR nr. 33593163resslifeinvestments.com To: Nasdaq CopenhagenDate: 17 April 2024 Corporate Announcement 15/2024 Ress Life Investments A/S publishes portfolio composition for Q1 2024 Ress Life Investments A/S hereby publishes a portfolio overview for the benefit of the company’s shareholders. Questions related to this announcement can be made to the company’s AIF-manager, Resscapital AB. Contact person: Gustaf Hagerudgustaf.hagerud@res

  • GlobeNewswire

    Ress Life Investments A/S, Decisions of annual general meeting 2024

    Ress Life Investments A/SNybrogade 12DK-1203 Copenhagen KDenmarkCVR nr. 33593163www.resslifeinvestments.comTo: Nasdaq CopenhagenDate: 17 April 2024 Corporate Announcement 14/2024 Ress Life Investments A/S announces the events of the annual general meeting held on 17 April 2024. At the annual general meeting of Ress Life Investments A/S held on Wednesday 17 April 2024, the following decisions were taken: • The Annual Report for the period 1 January - 31 December 2023 was approved – cf item 1 of t